Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Despite a revenue dip, HBIO maintains robust margins and advances strategic initiatives to bolster future growth.
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin